Basis: Trailing twelve months (TTM), to the latest fiscal quarter end. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on equity (ROE) high or low?
The return on equity (ROE) of -43.83% is 738% below its 5-year average of -5.23%, near the low end of its 5-year range (-43.83%–34.41%).
As of the fiscal period ended Tuesday, June 30, 2026. 737.54% below its 12-month average of 6.87%.
Trailing-twelve-month return on equity at each fiscal quarter end; no daily interpolation.
RETURN ON EQUITY (ROE)
-43.83%
RETURN ON EQUITY (ROE) AVG TTM
6.87%
RETURN ON EQUITY (ROE) AVG 3Y
6.59%
RETURN ON EQUITY (ROE) AVG 5Y
-5.23%
RETURN ON EQUITY (ROE) AVG 10Y
N/A
RETURN ON EQUITY (ROE) AVG 15Y
N/A
RETURN ON EQUITY (ROE) AVG 20Y
N/A
CURRENT VS TTM AVG
-737.54%
CURRENT VS 3Y AVG
-764.92%
CURRENT VS 5Y AVG
-738.01%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
13.25%
median of 83 covered companies
CURRENT VS SECTOR MEDIAN
-430.77%
vs the sector median at left
Hims & Hers Health, Inc.
Market Cap
$6.28B
Return on Equity (ROE)
-43.83%
TTM Avg
6.87%
3Y Avg
6.59%
5Y Avg
-5.23%
Market Cap
$6.78B
Return on Equity (ROE)
33.11%
TTM Avg
27.03%
3Y Avg
27.48%
5Y Avg
31.41%
Market Cap
$6.88B
Return on Equity (ROE)
-161.00%
TTM Avg
-110.38%
3Y Avg
-86.51%
5Y Avg
-75.97%
Market Cap
$5.22B
Return on Equity (ROE)
8.67%
TTM Avg
8.42%
3Y Avg
7.80%
5Y Avg
5.80%
Market Cap
$4.57B
Return on Equity (ROE)
18.24%
TTM Avg
20.62%
3Y Avg
17.32%
5Y Avg
27.02%
Market Cap
$8.56B
Return on Equity (ROE)
26.84%
TTM Avg
-21.41%
3Y Avg
-36.14%
5Y Avg
-25.75%
Market Cap
$3.05B
Return on Equity (ROE)
29.28%
TTM Avg
27.86%
3Y Avg
4.54%
5Y Avg
-12.45%
Market Cap
$9.85B
Return on Equity (ROE)
26.39%
TTM Avg
25.41%
3Y Avg
19.99%
5Y Avg
14.02%
Market Cap
$9.94B
Return on Equity (ROE)
15.51%
TTM Avg
15.81%
3Y Avg
15.92%
5Y Avg
17.27%
| NAME | MARKET CAP | RETURN ON EQUITY (ROE) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Hims & Hers Health, Inc. (HIMS) | $6.28B | -43.83% | 6.87% | 6.59% | -5.23% |
| Chemed Corporation (CHE)vs › | $6.78B | 33.11% | 27.03% | 27.48% | 31.41% |
| Scholar Rock Holding Corporation (SRRK)vs › | $6.88B | -161.00% | -110.38% | -86.51% | -75.97% |
| Merit Medical Systems, Inc. (MMSI)vs › | $5.22B | 8.67% | 8.42% | 7.80% | 5.80% |
| Doximity, Inc. (DOCS)vs › | $4.57B | 18.24% | 20.62% | 17.32% | 27.02% |
| Oscar Health, Inc. (OSCR)vs › | $8.56B | 26.84% | -21.41% | -36.14% | -25.75% |
| TransMedics Group, Inc. (TMDX)vs › | $3.05B | 29.28% | 27.86% | 4.54% | -12.45% |
| Insulet Corp. (PODD)vs › | $9.85B | 26.39% | 25.41% | 19.99% | 14.02% |
| The Ensign Group, Inc. (ENSG)vs › | $9.94B | 15.51% | 15.81% | 15.92% | 17.27% |
| Globus Medical, Inc. (GMED)vs › | $10.12B | 11.23% | 7.12% | 6.90% | 7.16% |
ROE
-43.8%
ROA
-3.9%
ROE = Net Income / Total Shareholders' Equity
Return on equity measures how efficiently a company generates profit from shareholders' equity. Higher ROE indicates better capital efficiency.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON EQUITY (ROE) |
|---|---|
| 2026-06-30 | -43.83% |
| 2026-03-31 | -2.97% |
| 2025-12-31 | 23.73% |
| 2025-09-30 | 23.03% |
| 2025-06-30 | 34.41% |
| 2025-03-31 | 29.93% |
| 2024-12-31 | 26.44% |
| 2024-09-30 | 23.01% |
| 2024-06-30 | 5.00% |
| 2024-03-31 | -0.68% |
| 2023-12-31 | -6.84% |
| 2023-09-30 | -10.86% |
| 2023-06-30 | -14.68% |
| 2023-03-31 | -19.02% |
| 2022-12-31 | -21.07% |
| 2022-09-30 | -27.64% |
| 2022-06-30 | -26.02% |
| 2022-03-31 | -22.13% |
| 2021-12-31 | -32.17% |
| 2021-09-30 | -23.01% |
| 2021-06-30 | -24.45% |
| 2021-03-31 | -21.71% |
| 2020-06-30 | -42.65% |
